Search Results 221-230 of 2776 for Erleada

  1. MBI Response toTam - Mayo Clinic

    About this study. The study will examine whether changes in background parenchymal uptake (BPU) on molecular breast imaging (MBI) can be induced by ...

  2. Study to Assess the Effects of Intravenous Bendavia in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA) - Mayo Clinic

    About this study. The primary objective of this trial is to assess the effects of Bendavia on renal blood flow and renal function in atherosclerotic renal ...

  3. Study Is To Assess The Safety And Tolerability Of VTx-002 In Participants With ALS - Mayo Clinic

    PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose, uncontrolled, first-in-human study that will evaluate the safety, tolerability and effects ...

  4. Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer - Mayo Clinic

    The purpose of this study is to determine freedom from ipsilateral breast recurrence occurrences in patients receiving partial breast proton radiation therapy ...

  5. Helmsley 3.0 Abbreviated Magnetic Resonance Enterography (MRE) - Mayo Clinic

    The purpose of our study is to compare a novel abbreviated MRE protocol to conventional, standard of care MRE in children and adults with CD at three large ...

  6. Financial Toxicity Among Patients in Phase I Clinical Trials

    As medical care in the United States becomes increasingly expensive, cost stewardship is a necessary component of delivering high value care. Cancer patients ...

  7. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors - Mayo Clinic

    About this study. This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, ...

  8. A Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Platinum-Refractory Metastatic Bladder Cancer - Mayo Clinic

    The purpose of this study is to evaluate the effect of combining ACP-196 and Pembrolizumab in subjects with platinum resistant metastatic bladder cancer.

  9. ACP Max Cellular Characterization At 90 ML Starting Volume - Mayo Clinic

    The aims of this study are to comprehensively characterize the cellular composition of PRP from ACP Max; quantify relevant cell types in PRP. Participation ...

  10. Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Patients Who Participated in ADDRESS II) - Mayo Clinic

    About this study. This is a multicenter, double-blind, Phase 2b, long-term extension (LTE) to the ADDRESS II core trial (EMR 700461-023) (NCT01972568), ...